A Study of PS-341 Given to Patients With Multiple Myeloma Who Experienced Progressive Disease After Receiving Dexamethasone in M34101-039

Institue Jules Bordet, Unite Sterile, Brussels

CHU Erasme / ULB University, Brussels

Wilhelminenspital Wien, Abt. Fur Med. und Medizinische Onkologie, Vienna

ACZA, Campus Stuivenberg, Antwerp

Erasmus MC, 1a, Daniel Den Hoed, Department of Hematology, Rotterdam

C.H. Notre Dame-Reine Fabiola, Department d'Oncologie et Hematolgie, Charleroi

AZ St. Jan, Dept of Haematology, Bruges

St. Vincent's Comprehensive Cancer Center, New York

Weill Medical College of Cornell University, NY Presbyterian Hospital, New York

Universitatsklinikum Charite Medizinische Klinik und Poliklinik, Berlin

Azienda Ospedaliera, S. Giovanni Battista, Torino

Long Island Jewish Medical Center, New Hyde Park

Huddinge University Hospital M54, Department of Haematology, Stockholm

Roswell Park Cancer Institute, Buffalo

Rochester General Hospital, Rochester

University of Rochester Medical Center, James P. Wilmot Cancer Center, Rochester

Western Pennsylvania Hospital, Pittsburgh

University of Pennsylvania Cancer Center, Philadelphia

Lombardi Cancer Center, Georgetown University Medical Center, Washington D.C.

Med Star Institute, Washington D.C.

Medical University Clinic (Oncology/Haematology), Hamburg

Charlotte Hematology Oncology Associates, Charlotte

Trident Palmetto Hematology/Oncology, Charleston

Emory University, Atlanta

Hopital Purpan, Pavillon Dieulafoy, Service d'Hematologie Clinique, Toulouse

Hematology/Oncology Associates, PA, Jacksonville

University of Miami, Miami

H. Lee Moffitt Cancer Center, Tampa

University Hospital of Salamanca, Hematology Dept, Salamanca

Cleveland Clinic Foundation, Cleveland

Uniklinikum Muenster, Medizinische Klinik und Poliklinik A, Münster

Medizinsche Klinik und Poliklinik 1, Rheinische Friedrich-Wilhelms-Universitaet, Bonn

Medical College of Wisconsin, Milwaukee

Hopital de Brabois, Vandœuvre-lès-Nancy

Johannes-Gutenberg-University Medical School, Department of Medicine III, Mainz

VA Medical Center, Minneapolis

Mayo Clinic, Rochester

Hospital Claude Huriez, Lille

Loyola University Medical Center: Cardinal Bernardin Cancer Center, Maywood

Northwestern University Medical School, Chicago

Washington University School of Medicine, St Louis

Universitatsklinikum Heidelberg, Heidelberg

Centre Hospitalier Lyon Sud, Cedex

LSU HC, Sheveport

University of Arkansas Medical Sciences, Little Rock

Hospital Saint-Louis, Paris

Hoptial Hotel Dieu, Paris

Texas Oncology at Medical City Dallas Hospital, Dallas

MD Anderson Cancer Center, Houston

City of Hope, Duarte

University of Erlangen-Nurenberg, Division of Hematology/Oncology, Erlangen

Hadassah University Hospital, Jerusalem

Hopital Antoine Beclere, Clamart

Scripps Clinic, Green Cancer Center, La Jolla

Loma Linda University Medical Center, Loma Linda

Kaiser Permanente Medical Center, Vallejo

Alta Bates Comprehensive Cancer Center, Berkeley

Fred Hutchinson Cancer Center, Seattle

Tufts England Medical Center, Boston

Mass General Hospital, Boston

Dana-Farber Cancer Center, Boston

Univ. of Michigan Comp. Cancer Center,, Ann Arbor

Hackensack University Medical Center, David Jurist Research Building, Hackensack

Division of Hematology/Stem Cell Transplant, Nashville

Cross Cancer Institute, Edmonton

London Health Sciences Center, London

Toronto General Research Institute, Toronto

McGill University Clinical Research Program, Montreal

Belfast City Hospital, Haematology Department, Belfast

Dipartimento di Biotecnologie Cellulari ed Ematologia, Az. Policlinico Umberto 1, Roma

Hospital Clinico Universitario de Barcelona, Hematologia, Barcelona

Adult Leukaemia Unit, Christie Hospital, Withington

Queen Elizabeth Hospital, Birmingham

Leeds General Infirmary, Department of Haematology, Leeds

Department of Haematology, ICSM, London

Royal Marsden Hospital, Sutton